Literature DB >> 2507134

Structure and expression of the rat c-jun messenger RNA: tissue distribution and increase during chemical hepatocarcinogenesis.

M Sakai1, A Okuda, I Hatayama, K Sato, S Nishi, M Muramatsu.   

Abstract

c-jun is the cellular homologue of the recently isolated nuclear oncogene v-jun. This protooncogene encodes the cellular transcription factor AP-1. We have isolated the complementary DNA clone of rat c-jun mRNA. The rat c-jun complementary DNA clone encodes 334 amino acid residues, the sequence of which shows about 98, 96, and 81% homologies with mouse, human, and chicken c-jun products, respectively. The c-jun mRNA is highly expressed in the lung and slightly expressed in the brain. The amount of mRNA is even smaller in the liver and is not detected in the spleen. We have also determined c-jun expression during chemical hepatocarcinogenesis and demonstrated increased expression of mRNA in the precancerous lesion, hyperplastic nodules, as well as in the primary hepatocellular carcinomas.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2507134

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  20 in total

1.  Context-dependent modulation of replication activity of Saccharomyces cerevisiae autonomously replicating sequences by transcription factors.

Authors:  H Kohzaki; Y Ito; Y Murakami
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

2.  Structural analysis of the mouse mdr1a (P-glycoprotein) promoter reveals the basis for differential transcript heterogeneity in multidrug-resistant J774.2 cells.

Authors:  S I Hsu; D Cohen; L S Kirschner; L Lothstein; M Hartstein; S B Horwitz
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

3.  Phosphorylation of c-Jun stimulated in primary cultured rat liver parenchymal cells by a coplanar polychlorinated biphenyl.

Authors:  K Tanno; Y Aoki
Journal:  Biochem J       Date:  1996-02-01       Impact factor: 3.857

Review 4.  Biochemical, genetic, and metabolic adaptations of tumor cells that express the typical multidrug-resistance phenotype. Reversion by new therapies.

Authors:  L G Baggetto
Journal:  J Bioenerg Biomembr       Date:  1997-08       Impact factor: 2.945

5.  Differentiation of F9 embryonal carcinoma cells induced by the c-jun and activated c-Ha-ras oncogenes.

Authors:  Y Yamaguchi-Iwai; M Satake; Y Murakami; M Sakai; M Muramatsu; Y Ito
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

6.  Regulation of proto-oncogene expression in adult and developing lungs.

Authors:  R Molinar-Rode; R J Smeyne; T Curran; J I Morgan
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

7.  Tissue-specific activation of tumor marker glutathione transferase P transgenes in transgenic rats.

Authors:  T Suzuki; M Imagawa; K Nomura; S Hochi; M Hirabayashi; M Ueda; T Kitagawa; M Muramatsu
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

8.  The nuclear protooncogenes c-jun and c-fos as regulators of DNA replication.

Authors:  Y Murakami; M Satake; Y Yamaguchi-Iwai; M Sakai; M Muramatsu; Y Ito
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

9.  Expression of immediate early genes in rat gastric myenteric neurones: a physiological response to feeding.

Authors:  R Dimaline; S M Miller; D Evans; P J Noble; P Brown; J A Poat
Journal:  J Physiol       Date:  1995-10-15       Impact factor: 5.182

10.  Expression of ileal glucagon and peptide tyrosine-tyrosine genes. Response to inhibition of polyamine synthesis in the presence of massive small-bowel resection.

Authors:  R G Taylor; D J Beveridge; P J Fuller
Journal:  Biochem J       Date:  1992-09-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.